Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00480362
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
368 | (1R)-2-{[AMINO(IMINO)METHYL]AMINO}- 1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2- DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE | A | 1ZLR | 0.77 | |
NIX | NALIDIXIC ACID | A,B | 2BQ2 | 0.79 | |
G14 | 2-phenyl-1H-imidazole-4-carboxylic acid | A,B | 3GRJ | 0.71 | |
985 | (2E)-3-{3-[6-(4-methyl-1,4-diazepan- 1-yl)pyrazin-2-yl]phenyl}prop-2- enoic acid | A | 3F2A | 0.75 | |
G44 | 4-({[4-(3-METHYLBENZOYL)PYRIDIN- 2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE | C,D | 2PKS | 0.7 | |
NCN | NICOTINATE MONONUCLEOTIDE | A,B | 2QTN | 0.73 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4F | 0.73 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4L | 0.73 | |
NCN | NICOTINATE MONONUCLEOTIDE | A,B,C,D | 1YUM | 0.73 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4M | 0.73 | |
NCN | NICOTINATE MONONUCLEOTIDE | A,B,C,D,E,F | 1QPN | 0.73 | |
NCN | NICOTINATE MONONUCLEOTIDE | A,B,C | 2B7Q | 0.73 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4K | 0.73 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4G | 0.73 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1YTK | 0.73 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L4H | 0.73 | |
NCN | NICOTINATE MONONUCLEOTIDE | A | 1L5O | 0.73 | |
IQA | (5-OXO-5,6-DIHYDRO-INDOLO[1,2-A]QUINAZOLIN- 7-YL)-ACETIC ACID | A | 1OM1 | 0.71 | |
PRC | N-[4-METHYL-3-[[4-(3-PYRIDINYL)- 2-PYRIMIDINYL]AMINO]PHENYL]-3-PYRIDINECARBOXAMIDE | A,B | 1FPU | 0.7 | |
NNO | 6-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCK | 0.75 | |
NNO | 6-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCM | 0.75 | |
NA4 | 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)- PYRIDIN-3-YL]-BENZOIC ACID | A,C | 1RHM | 0.73 | |
AXD | 2-[4-({2-[(2S,5R)-2-(AMINOMETHYL)- 5-ETHYNYLPYRROLIDIN-1-YL]-2-OXOETHYL}AMINO)- 4-METHYLPIPERIDIN-1-YL]ISONICOTINIC ACID | B | 2I03 | 0.8 | |
NFL | 2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID | A | 1TD7 | 0.88 | |
ICO | 1H-INDOLE-3-CARBOXYLIC ACID | L | 2PIP | 0.7 | |
MMG | 4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin- 3-yl)benzoic acid | A | 3HDM | 0.75 | |
PT1 | PTEROIC ACID | A,B | 1TX0 | 0.72 | |
PT1 | PTEROIC ACID | A | 1BR6 | 0.72 | |
PT1 | PTEROIC ACID | A,B | 1HWP | 0.72 | |
1PU | 1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H- PYRROLO[2,1-A]ISOINDOL-9-YL)-3- PYRIDIN-2-YL-UREA | A | 1GII | 0.7 | |
1PU | 1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H- PYRROLO[2,1-A]ISOINDOL-9-YL)-3- PYRIDIN-2-YL-UREA | A | 1GIH | 0.7 | |
LG2 | 6-[1-(3,5,5,8,8-PENTAMETHYL-5,6,7,8- TETRAHYDRONAPHTHALEN-2-YL)CYCLOPROPYL]PYRIDINE- 3-CARBOXYLIC ACID | A,B,C,D | 1H9U | 0.74 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D,E,F | 1KQO | 0.72 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 2H29 | 0.72 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1NUQ | 0.72 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A | 1WXG | 0.72 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D,E,F | 1KAQ | 0.72 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1EE1 | 0.72 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D | 3E27 | 0.72 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A | 1XQD | 0.72 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 2H2A | 0.72 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1IFX | 0.72 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1XNG | 0.72 | |
859 | 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN- 4-YL}AMINO)BENZAMIDE | A,B | 2NO3 | 0.76 | |
TRN | NZ2-TRYPTOPHAN | A,B,C | 1AM7 | 0.74 | |
24X | H,L | 2EC9 | 0.78 | ||
INO | 2-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCL | 0.7 | |
INO | 2-HYDROXYISONICOTINIC ACID N-OXIDE | M,N,O,P,Q,R | 3PCJ | 0.7 | |
4RB | 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2- b]pyridazin-3-yl)benzoic acid | A | 3BQR | 0.72 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1S1X | 0.75 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LWE | 0.75 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LW0 | 0.75 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 2HND | 0.75 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1FKP | 0.75 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1S1U | 0.75 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LWF | 0.75 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 2HNY | 0.75 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1VRT | 0.75 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LWC | 0.75 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1JLB | 0.75 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 3HVT | 0.75 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1JLF | 0.75 | |
608 | N-(4-phenoxyphenyl)-2-[(pyridin- 4-ylmethyl)amino]nicotinamide | A,B | 2P2I | 0.72 | |
U05 | 6,11-DIHYDRO-11-ETHYL-6-METHYL- 9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN- 5-ONE | A | 1RTH | 0.71 | |
U05 | 6,11-DIHYDRO-11-ETHYL-6-METHYL- 9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN- 5-ONE | A | 1RT3 | 0.71 | |
U05 | 6,11-DIHYDRO-11-ETHYL-6-METHYL- 9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN- 5-ONE | A | 1LW2 | 0.71 | |
PBO | 1-PYRIDIN-3-YLBUTAN-1-ONE | A | 1PYJ | 0.72 | |
NIO | NICOTINIC ACID | A | 1JHQ | 0.82 | |
NIO | NICOTINIC ACID | A | 1L5L | 0.82 | |
NIO | NICOTINIC ACID | A | 2F7F | 0.82 | |
NIO | NICOTINIC ACID | A | 1L5K | 0.82 | |
NIO | NICOTINIC ACID | A | 1JHY | 0.82 | |
NIO | NICOTINIC ACID | A,B | 1FSL | 0.82 | |
NIO | NICOTINIC ACID | A | 1L5M | 0.82 | |
NIO | NICOTINIC ACID | A | 1LH6 | 0.82 | |
NIO | NICOTINIC ACID | A | 1JHO | 0.82 | |
NIO | NICOTINIC ACID | A | 3CI8 | 0.82 | |
NIO | NICOTINIC ACID | A,B,C,D | 1ICU | 0.82 | |
NIO | NICOTINIC ACID | A,B,C,D,E,F, G,H | 3HRD | 0.82 | |
NIO | NICOTINIC ACID | A | 1JHA | 0.82 | |
NIO | NICOTINIC ACID | A | 1JHV | 0.82 | |
NIO | NICOTINIC ACID | A | 1L4N | 0.82 | |
NIO | NICOTINIC ACID | A | 2LH6 | 0.82 | |
NIO | NICOTINIC ACID | A | 1D0V | 0.82 | |
NIO | NICOTINIC ACID | A,B,C,D | 1ICV | 0.82 | |
NIO | NICOTINIC ACID | A,B | 1ICR | 0.82 | |
NIO | NICOTINIC ACID | A | 1JHR | 0.82 | |
OQB | 4-OXO-3-[(6-{[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-METHYL}-PYRIDINE- 3-CARBONYL)-AMINO]-BUTYRIC ACID | A | 1RWW | 0.71 | |
PD8 | PHOSPHORYLATED DIHYDROPTEROATE | A | 1W78 | 0.71 | |
BP5 | 3-(2,2'-BIPYRIDIN-5-YL)-L-ALANINE | A | 2PXH | 0.72 | |
PD2 | PYRIDINE-2,4-DICARBOXYLIC ACID | A,B,C | 2W2I | 0.71 | |
PD2 | PYRIDINE-2,4-DICARBOXYLIC ACID | A | 2GKL | 0.71 | |
PD2 | PYRIDINE-2,4-DICARBOXYLIC ACID | A,B | 2VD7 | 0.71 | |
PD2 | PYRIDINE-2,4-DICARBOXYLIC ACID | A,B | 2JIG | 0.71 | |
7CS | (3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT- 3-YL 1H-PYRROLO[2,3-B]PYRIDINE- 3-CARBOXYLATE | A | 2QHM | 0.75 | |
218 | 1-[(4-AMINO-2-METHYLPYRIMIDIN-5- YL)METHYL]-3-(2-HYDROXYETHYL)-2- METHYLPYRIDINIUM | A | 2HOP | 0.71 | |
PRR | 3-(METHYL-PYRIDINIUM)ALANINE | H,I,J | 7KME | 0.72 | |
LYA | 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO- 3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)- ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID | A,B,C,D | 1JUJ | 0.71 | |
LYA | 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO- 3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)- ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID | A,B,C,D | 1JU6 | 0.71 | |
MYT | METYRAPONE | A | 1PHG | 0.72 | |
MYT | METYRAPONE | A | 1W0G | 0.72 | |
NNR | Nicotinamide riboside | A | 2QT0 | 0.7 | |
NNR | Nicotinamide riboside | A | 2QT1 | 0.7 | |
APT | 2-AMINO-6-[(4-CARBOXY-PHENYLAMINO)- METHYL]-4-HYDROXY-PTERIDIN-1-IUM | A,B | 1QCJ | 0.71 | |
DZF | 5-DEAZAFOLIC ACID | A,B | 2DHF | 0.73 | |
DZF | 5-DEAZAFOLIC ACID | A,B | 1DYH | 0.73 | |
DZF | 5-DEAZAFOLIC ACID | A,B,C,D | 1CDE | 0.73 | |
6PC | PYRIDINE-2-CARBOXYLIC ACID | A | 2OLN | 0.71 | |
6PC | PYRIDINE-2-CARBOXYLIC ACID | A | 2OLO | 0.71 | |
VAR | 9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2- c]pyrimidin-4-ol | A,B,C,D | 3BHV | 0.71 | |
NTM | QUINOLINIC ACID | A | 3C2O | 0.77 | |
NTM | QUINOLINIC ACID | A,B | 1QAP | 0.77 | |
NTM | QUINOLINIC ACID | A,B,C,D,E,F | 1QPQ | 0.77 | |
NTM | QUINOLINIC ACID | A,B,C | 2B7N | 0.77 | |
AT2 | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE- 1-CARBOXYLATE | A,B | 3E7S | 0.71 | |
AT2 | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE- 1-CARBOXYLATE | A,B | 3E7M | 0.71 | |
AT2 | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE- 1-CARBOXYLATE | A,B,C,D | 3E7G | 0.71 | |
3HM | 5-hydroxy-6-methylpyridine-3-carboxylic acid | A,B | 3GMC | 0.7 | |
PAA | (N-METHYLPYRIDYL)ACETIC ACID | I | 1HBT | 0.73 | |
NXX | A,B,C,D | 3DLA | 0.72 | ||
NXX | A,B,C | 2QTR | 0.72 | ||
D3E | N-cyclopropyl-N-(trans-4-pyridin- 3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro- 1-hydroxy-1-methylethyl]benzamide | A,B,C,D | 3D3E | 0.7 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z8C | 0.76 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z7L | 0.76 | |
PMC | 3-(PHOSPHONOMETHYL)PYRIDINE-2-CARBOXYLIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 1I43 | 0.71 |